PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
Cinchona bark and its derivative quinine were the only effective large-scale treatments for malaria until the 20th century [PMID:40814135]. Quinine is still prescribed in severe malaria and resource-limited settings [PMID:30477182].
Cinchona officinalis extract-loaded iron oxide nanoparticles induced cytotoxicity and apoptosis in MCF-7 human breast cancer cells [PMID:36234520]. Quinine-derived organocatalysts showed in vitro anticancer activity against uterine sarcoma cell lines [PMID:35640378].
Quinidine has had a limited comeback in the treatment of several cardiac and neurological syndromes [PMID:30477182].
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 41851462 (2026) — Biosynthesis of cinchona alkaloids. · Nature
- 2.PMID: 30850032 (2019) — Cinchona Alkaloids-Derivatives and Applications. · The Alkaloids. Chemistry and biology
- 3.PMID: 40814135 (2025) — Cinchona bark and quinine as psychiatric treatments in Portugal, 1700-1900. · Die Pharmazie
- 4.PMID: 39696770 (2024) — Essay review: the fictive history of Victorian science and empire. · British journal for the history of science
- 5.PMID: 36199186 (2022) — Cinchona bark and quinine in the Portuguese official pharmacopoeias (1794-2001). · Die Pharmazie